Radiopharmaceuticals for diagnosis in nuclear medicine: a short review

Radiopharmaceuticals are radioactive compounds which have a bound radionuclide in their structure, whose purpose is directing the radionuclide to a location to be treated or to obtain images. Nuclear medicine is the medical specialty that employs radiopharmaceuticals, which has presented itself as a...

Full description

Bibliographic Details
Main Authors: Filipe Boccato Payolla, Antonio Carlos Massabni, Chris Orvig
Format: Article
Language:English
Published: Universidade Estadual Paulista 2019-07-01
Series:Eclética Química
Online Access:https://revista.iq.unesp.br/ojs/index.php/ecletica/article/view/1032
_version_ 1818307429292572672
author Filipe Boccato Payolla
Antonio Carlos Massabni
Chris Orvig
author_facet Filipe Boccato Payolla
Antonio Carlos Massabni
Chris Orvig
author_sort Filipe Boccato Payolla
collection DOAJ
description Radiopharmaceuticals are radioactive compounds which have a bound radionuclide in their structure, whose purpose is directing the radionuclide to a location to be treated or to obtain images. Nuclear medicine is the medical specialty that employs radiopharmaceuticals, which has presented itself as a tremendously useful ally for medicine assisting in various diagnoses and treatments, especially for cancer. The general objective of this work is to identify the main radionuclides and metal complexes currently used as radiopharmaceuticals. The main metal complexes used as radiopharmaceuticals are compounds of technetium (99mTc) like sodium pertechnetate and methylenediphosphonate MDP-99mTc and other compounds of indium (111In), thallium (201Tl), gallium (67Ga, 68Ga), iodine (123I and 131I), chromium (51Cr), sulphur (35S), phosphorus (32P), fluorine (as fluorodeoxyglucose, 18F-FDG and sodium fluorine, Na18F), which are widely used in the nuclear medicine for diagnosis by imaging. They have been of great importance for the early diagnosis of numerous diseases, mainly cancer.Currently, technetium compounds are the majority of radiopharmaceuticals used in all countries. In Brazil, Institute of Energy and Nuclear Research (IPEN) is one of the most important distributors of radiopharmaceuticals, producing, importing and distributing them to clinics and hospitals over the country.
first_indexed 2024-12-13T06:58:14Z
format Article
id doaj.art-afcc1ae76c9544f6903bfb09e9817e2d
institution Directory Open Access Journal
issn 1678-4618
language English
last_indexed 2024-12-13T06:58:14Z
publishDate 2019-07-01
publisher Universidade Estadual Paulista
record_format Article
series Eclética Química
spelling doaj.art-afcc1ae76c9544f6903bfb09e9817e2d2022-12-21T23:56:00ZengUniversidade Estadual PaulistaEclética Química1678-46182019-07-01443111910.26850/1678-4618eqj.v44.3.2019.p11-191032Radiopharmaceuticals for diagnosis in nuclear medicine: a short reviewFilipe Boccato Payolla0Antonio Carlos Massabni1Chris Orvig2University of Araraquara (Uniara), 1217 Carlos Gomes St., Araraquara, São Paulo, BrazilInstitute of Chemistry Unesp Araraquara (Unesp); University of Araraquara (Uniara)Medicinal Inorganic Chemistry Group, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1Radiopharmaceuticals are radioactive compounds which have a bound radionuclide in their structure, whose purpose is directing the radionuclide to a location to be treated or to obtain images. Nuclear medicine is the medical specialty that employs radiopharmaceuticals, which has presented itself as a tremendously useful ally for medicine assisting in various diagnoses and treatments, especially for cancer. The general objective of this work is to identify the main radionuclides and metal complexes currently used as radiopharmaceuticals. The main metal complexes used as radiopharmaceuticals are compounds of technetium (99mTc) like sodium pertechnetate and methylenediphosphonate MDP-99mTc and other compounds of indium (111In), thallium (201Tl), gallium (67Ga, 68Ga), iodine (123I and 131I), chromium (51Cr), sulphur (35S), phosphorus (32P), fluorine (as fluorodeoxyglucose, 18F-FDG and sodium fluorine, Na18F), which are widely used in the nuclear medicine for diagnosis by imaging. They have been of great importance for the early diagnosis of numerous diseases, mainly cancer.Currently, technetium compounds are the majority of radiopharmaceuticals used in all countries. In Brazil, Institute of Energy and Nuclear Research (IPEN) is one of the most important distributors of radiopharmaceuticals, producing, importing and distributing them to clinics and hospitals over the country.https://revista.iq.unesp.br/ojs/index.php/ecletica/article/view/1032
spellingShingle Filipe Boccato Payolla
Antonio Carlos Massabni
Chris Orvig
Radiopharmaceuticals for diagnosis in nuclear medicine: a short review
Eclética Química
title Radiopharmaceuticals for diagnosis in nuclear medicine: a short review
title_full Radiopharmaceuticals for diagnosis in nuclear medicine: a short review
title_fullStr Radiopharmaceuticals for diagnosis in nuclear medicine: a short review
title_full_unstemmed Radiopharmaceuticals for diagnosis in nuclear medicine: a short review
title_short Radiopharmaceuticals for diagnosis in nuclear medicine: a short review
title_sort radiopharmaceuticals for diagnosis in nuclear medicine a short review
url https://revista.iq.unesp.br/ojs/index.php/ecletica/article/view/1032
work_keys_str_mv AT filipeboccatopayolla radiopharmaceuticalsfordiagnosisinnuclearmedicineashortreview
AT antoniocarlosmassabni radiopharmaceuticalsfordiagnosisinnuclearmedicineashortreview
AT chrisorvig radiopharmaceuticalsfordiagnosisinnuclearmedicineashortreview